Professional Insights for Healthcare Leaders Sales organizations frequently compromise their own leverage when dealing with established clients. Rather than capitalising... Read more
Category: Uncategorized
Kenvue beats first-quarter estimates amid pending $40 billion acquisition by Kimberly-Clark
Kenvue Inc., the maker of Tylenol, beat Wall Street estimates for first-quarter revenue and profit on Thursday. The positive performance... Read more
GSK licenses Halozyme ENHANZE for subcutaneous cancer drugs, including ADCs
Halozyme Therapeutics Inc. and GSK have entered into a global collaboration and license agreement. Under the terms, GSK has licensed... Read more
Altasciences and Certara partner to accelerate early-phase drug development
Altasciences, an integrated drug development solution company, and Certara, a global leader in model-informed drug development, have launched a strategic... Read more
Blackstone Life Sciences invests $250M in Anagram Therapeutics for Pancreatic Enzyme Replacement Therapy
Blackstone Life Sciences is making a $250 million investment in Anagram Therapeutics, a clinical-stage biopharmaceutical company. The funding is designated... Read more
Eli Lilly pledges additional $4.5B to build the largest API manufacturing site in US history
Pharmaceutical giant Eli Lilly has unveiled plans to invest an additional $4.5 billion into its Lebanon campus in Indiana. This... Read more
Novo Nordisk kicks off 2026 with a strong start led by oral obesity “Trump Card”
After a period of volatility, Danish pharmaceutical giant Novo Nordisk reported positive signals in Q1 2026. The most significant highlight... Read more
Sanofi requests to withdraw Tzield application from FDA’s controversial CNPV program
French pharmaceutical giant Sanofi has reportedly requested to remove its application for the expanded use of the diabetes drug Tzield... Read more
Angelini Pharma acquires Catalyst for $4.1B to fulfill U.S. growth ambitions
Angelini Pharma, a historic Italian family-owned company, has announced a $4.1 billion agreement to acquire Florida-based Catalyst Pharmaceuticals. This marks... Read more









